Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 987-24-6
2. Betamethasone 21-acetate
3. Beta-methasone Acetate
4. Ti05ao53l7
5. Chebi:31275
6. 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-acetate
7. Nsc-759196
8. (11b,16a)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 21-acetate
9. (11beta,16beta)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
10. 9-fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
11. [2-[(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate
12. Betamethasone Acetate [jan]
13. Unii-ti05ao53l7
14. Betamethasone Acetate [usp:jan]
15. Betamethasone-acetate
16. Einecs 213-578-6
17. 9alpha-fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 21-acetate
18. Betamethason-21-acetat
19. Schembl7592
20. Betamethasone21-acetate
21. Chembl1200538
22. Dtxsid8022668
23. Betamethasone Acetate (jan/usp)
24. 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 21-acetate
25. Amy39051
26. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(acetyloxy)-, (11.beta.,16.beta.)-
27. Zinc4212130
28. Betamethasone Acetate [vandf]
29. Betamethasone Acetate [mart.]
30. Akos015896575
31. Betamethasone Acetate [usp-rs]
32. Betamethasone Acetate [who-dd]
33. Nsc 759196
34. Betamethasone Acetate [green Book]
35. Betamethasone Acetate [ep Impurity]
36. Betamethasone Acetate [orange Book]
37. Betamethasone Acetate [ep Monograph]
38. B3165
39. Betamethasone Acetate [usp Monograph]
40. Osurnia Component Betamethasone Acetate
41. D01402
42. T71509
43. Betamethasone Acetate 100 Microg/ml In Methanol
44. Betamethasone Acetate Component Of Osurnia
45. 987m246
46. Betamethasone Valerate Impurity A [ep Impurity]
47. Dexamethasone Acetate Impurity D [ep Impurity]
48. Q27114254
49. Celestone Soluspan Component Betamethasone Acetate
50. Betamethasone Acetate Component Of Celestone Soluspan
51. Betamethasone Acetate, European Pharmacopoeia (ep) Reference Standard
52. Betamethasone Acetate, United States Pharmacopeia (usp) Reference Standard
53. Betamethasone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
54. 9alpha-fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
55. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16beta)-
56. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(acetyloxy)-, (11beta,16beta)-
Molecular Weight | 434.5 g/mol |
---|---|
Molecular Formula | C24H31FO6 |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 434.21046687 g/mol |
Monoisotopic Mass | 434.21046687 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 910 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Betamethasone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betamethasone Acetate manufacturer or Betamethasone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betamethasone Acetate manufacturer or Betamethasone Acetate supplier.
PharmaCompass also assists you with knowing the Betamethasone Acetate API Price utilized in the formulation of products. Betamethasone Acetate API Price is not always fixed or binding as the Betamethasone Acetate Price is obtained through a variety of data sources. The Betamethasone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CELESTONE SOLUSPAN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CELESTONE SOLUSPAN, including repackagers and relabelers. The FDA regulates CELESTONE SOLUSPAN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CELESTONE SOLUSPAN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CELESTONE SOLUSPAN manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CELESTONE SOLUSPAN supplier is an individual or a company that provides CELESTONE SOLUSPAN active pharmaceutical ingredient (API) or CELESTONE SOLUSPAN finished formulations upon request. The CELESTONE SOLUSPAN suppliers may include CELESTONE SOLUSPAN API manufacturers, exporters, distributors and traders.
click here to find a list of CELESTONE SOLUSPAN suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CELESTONE SOLUSPAN DMF (Drug Master File) is a document detailing the whole manufacturing process of CELESTONE SOLUSPAN active pharmaceutical ingredient (API) in detail. Different forms of CELESTONE SOLUSPAN DMFs exist exist since differing nations have different regulations, such as CELESTONE SOLUSPAN USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CELESTONE SOLUSPAN DMF submitted to regulatory agencies in the US is known as a USDMF. CELESTONE SOLUSPAN USDMF includes data on CELESTONE SOLUSPAN's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CELESTONE SOLUSPAN USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CELESTONE SOLUSPAN suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CELESTONE SOLUSPAN Drug Master File in Japan (CELESTONE SOLUSPAN JDMF) empowers CELESTONE SOLUSPAN API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CELESTONE SOLUSPAN JDMF during the approval evaluation for pharmaceutical products. At the time of CELESTONE SOLUSPAN JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CELESTONE SOLUSPAN suppliers with JDMF on PharmaCompass.
A CELESTONE SOLUSPAN written confirmation (CELESTONE SOLUSPAN WC) is an official document issued by a regulatory agency to a CELESTONE SOLUSPAN manufacturer, verifying that the manufacturing facility of a CELESTONE SOLUSPAN active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CELESTONE SOLUSPAN APIs or CELESTONE SOLUSPAN finished pharmaceutical products to another nation, regulatory agencies frequently require a CELESTONE SOLUSPAN WC (written confirmation) as part of the regulatory process.
click here to find a list of CELESTONE SOLUSPAN suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CELESTONE SOLUSPAN as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CELESTONE SOLUSPAN API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CELESTONE SOLUSPAN as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CELESTONE SOLUSPAN and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CELESTONE SOLUSPAN NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CELESTONE SOLUSPAN suppliers with NDC on PharmaCompass.
CELESTONE SOLUSPAN Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CELESTONE SOLUSPAN GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CELESTONE SOLUSPAN GMP manufacturer or CELESTONE SOLUSPAN GMP API supplier for your needs.
A CELESTONE SOLUSPAN CoA (Certificate of Analysis) is a formal document that attests to CELESTONE SOLUSPAN's compliance with CELESTONE SOLUSPAN specifications and serves as a tool for batch-level quality control.
CELESTONE SOLUSPAN CoA mostly includes findings from lab analyses of a specific batch. For each CELESTONE SOLUSPAN CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CELESTONE SOLUSPAN may be tested according to a variety of international standards, such as European Pharmacopoeia (CELESTONE SOLUSPAN EP), CELESTONE SOLUSPAN JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CELESTONE SOLUSPAN USP).